Researcher
Hans Wildiers
- Keywords:Medicine
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 18 results
- Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patientsFrom1 Apr 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- The MBC biobank collection.From1 Dec 2020 → TodayFunding: Other federal public and semi-governmental institutions
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Jul 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of lipid metabolism in metastasis formationFrom13 Jan 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Linking patient adiposity to tumour microenvironment and therapy response in breast cancer: towards tailored treatment strategies in obesityFrom27 Sep 2019 → TodayFunding: FWO Strategic Basic Research Grant, Foundations, funds and other with scientific goal
- Hormone-sensitive breast cancer: Tumor biology, prognostic/predictive biomarkers and specific treatment approachesFrom1 Sep 2019 → TodayFunding: Foundations, funds and other with scientific goal
- A metabolomics signature on liquid biopsy as a prognostic and predictive biomarker in early breast cancerFrom1 Jan 2019 → TodayFunding: Foundations, funds and other with scientific goal
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- BIOMEX: a software to alleviate the bottlenecks in the analysis-to-interpretation pipeline of omics datasetsFrom27 Jun 2016 → 19 Jan 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- OPTImisation of cancer treatment in AGEd persons : integration of geriatric assessment and aging biomarker analysis in elderly clinical cancer trialsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project
Publications
1 - 10 of 316 results
- Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors.(2021)
Authors: Elke Lodewijckx, Cindy Kenis, Johan Flamaing, Pascal Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, et al.
Pages: 368 - 374 - Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.(2021)
Authors: Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey, Daniele Generali, et al.
Pages: 162 - 172 - Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.(2021)
Authors: Giuseppe Floris, François Richard, Anne-Sophie Hamy, Lynn Jongen, Hans Wildiers, Jan Ardui, Kevin Punie, Ann Smeets, Patrick Berteloot, Ignace Vergote, et al.
Pages: 146 - 153 - CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers(2021)
Authors: Nichola Johnson, Sarah Maguire, Anna Morra, Pooja Middha Kapoor, Katarzyna Tomczyk, Michael E Jones, Minouk J Schoemaker, Clare Gilham, Manjeet K Bolla, Qin Wang, et al.
Pages: 842 - 854Number of pages: 13 - Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situation(2021)
Authors: Ben Sprangers, Annelien van der Veen, Marije E Hamaker, Siri Rostoft, Sheron Latcha, Stuart M Lichtman, Bart De Moor, Hans Wildiers
Pages: e42 - e52Number of pages: 11 - Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials(2021)
Authors: Matthew P Goetz, Meena Okera, Hans Wildiers, Mario Campone, Eva-Maria Grischke, Luis Manso, Valerie AM Andre, Nadia Chouaki, Belen San Antonio, Masakazu Toi, et al.
Pages: 417 - 428Number of pages: 12 - Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative(2021)
Authors: Martine Extermann, Etienne Brain, Beverly Canin, Meena Nathan Cherian, Kwok-Leung Cheung, Nienke de Glas, Beena Devi, Marije Hamaker, Ravindran Kanesvaran, Theodora Karnakis, et al.
Pages: e29 - e36 - Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells(2020)
Authors: Clara Gomez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernandez-Jimenez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, et al.
Number of pages: 18 - Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group(2020)
Authors: Nicolo Matteo Luca Battisti, Anna Rachelle Mislang, Lisa Cooper, Anita O'Donovan, Riccardo A Audisio, Kwok-Leung Cheung, Regina Girones Sarrio, Reinhard Stauder, Enrique Soto-Perez-de-Celis, Michael Jaklitsch, et al.
Pages: 1190 - 1198Number of pages: 9 - Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations(2020)
Authors: Liesbeth Lenaerts, Huiwen Che, Nathalie Brison, Maria Neofytou, Tatjana Jatsenko, Hanne Lefrere, Charlotte Maggen, Darine Villela, Magali Verheecke, Luc Dehaspe, et al.
Pages: 1414 - 1423Number of pages: 10